ABK Biomedical Funding: $35M Raised, Series D (2025)
ABK Biomedical is based in Halifax, NS, Canada. It has raised $35M in total funding. Latest round: Series D.
ABK Biomedical funding overview
ABK Biomedical is based in Halifax, NS, Canada. ABK Biomedical has raised $35M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series D announced in October 2025. The round record for ABK Biomedical runs through 2025; nothing later has been disclosed. Investors on record include J.P. Morgan Life Sciences Private Capital, F-Prime, Santé··Ventures, Eight Roads Ventures, Varian Medical Systems. 5 distinct backers are named across the disclosed rounds.
ABK Biomedical at a glance
Total raised
$35M
Latest round
Series D
Latest round date
October 2025
Headquarters
Halifax, NS, Canada
Notable investors
J.P. Morgan Life Sciences Private Capital, F-Prime, Santé··Ventures, Eight Roads Ventures, Varian Medical Systems
Frequently asked about ABK Biomedical funding
How much has ABK Biomedical raised?
ABK Biomedical has raised $35M in total disclosed funding across the rounds on record.
Who has invested in ABK Biomedical?
J.P. Morgan Life Sciences Private Capital, F-Prime, Santé··Ventures, Eight Roads Ventures, Varian Medical Systems are named among the investors backing ABK Biomedical.
What was the latest ABK Biomedical funding round?
The most recent disclosed round is a Series D, announced in October 2025.
Where is ABK Biomedical based?
ABK Biomedical is based in Halifax, NS, Canada.
When did ABK Biomedical last raise?
The last disclosed ABK Biomedical round closed in October 2025 at Series D.
Every ABK Biomedical figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in Halifax at a similar stage.
